These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2464195)

  • 21. Reactogenicity and immunogenicity of oral cholera vaccine in Thai volunteers.
    Migasena S; Pitisuttitham P; Supanaranond W; Desakorn V; Prayurahong B; Suntharasamai P
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):423-8. PubMed ID: 3217824
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of vaccines against cholera and diarrhoea due to enterotoxigenic Escherichia coli: memorandum from a WHO meeting.
    Bull World Health Organ; 1990; 68(3):303-12. PubMed ID: 2203550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens.
    Gentschev I; Spreng S; Sieber H; Ures J; Mollet F; Collioud A; Pearman J; Griot-Wenk ME; Fensterle J; Rapp UR; Goebel W; Rothen SA; Dietrich G
    Chemotherapy; 2007; 53(3):177-80. PubMed ID: 17347563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design of Salmonella recombinant vaccines.
    Cheminay C; Hensel M
    Int J Med Microbiol; 2008 Jan; 298(1-2):87-98. PubMed ID: 17888730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunisation against cholera with a Ty21a-cholera hybrid.
    La Brooy JT; Forrest B; Bartholomeusz C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
    [No Abstract]   [Full Text] [Related]  

  • 27. [Conjugate vaccines against bacterial infections: typhoid fever].
    Paniagua J; García JA; López CR; González CR; Isibasi A; Kumate J
    Salud Publica Mex; 1992; 34(3):268-73. PubMed ID: 1377407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single shot at Salmonella typhi: a new typhoid vaccine with pediatric advantages.
    Hall CB
    Pediatrics; 1995 Aug; 96(2 Pt 1):348-50. PubMed ID: 7630698
    [No Abstract]   [Full Text] [Related]  

  • 29. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
    Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
    Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Infection; 1985; 13 Suppl 2():S206-10. PubMed ID: 3902655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in mucosal vaccines for the control of infectious diseases.
    Azegami T; Yuki Y; Kiyono H
    Int Immunol; 2014 Sep; 26(9):517-28. PubMed ID: 24914172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenic complexes obtained from Salmonella typhi-murium and Salmonella typhi Ty2 by the bacterial acetone powder method.
    Tato P; Flisser A; Gavilanes M; Molinari JL
    Ann Microbiol (Paris); 1979 Jan; 130 A(1):47-60. PubMed ID: 382951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental justification for combined subcutaneous immunization against cholera and typhoid fever].
    Gapochko KG; Emel'ianova OV; Ziablitsev IF
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):85-9. PubMed ID: 6702364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The new problem of typhoid fever in Papua New Guinea: how do we deal with it?
    Passey M
    P N G Med J; 1995 Dec; 38(4):300-4. PubMed ID: 9522872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Emergency prophylaxis of typhoid using the Vi-antigen of typhoid bacteria].
    D'iachenko PN; Dzhumaliev ND; Il'in VI; Pavlova TE
    Zdravookhr Kirg; 1976; (6):32-5. PubMed ID: 13578
    [No Abstract]   [Full Text] [Related]  

  • 36. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
    J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)].
    Meshalova AN; Kurlova VI; Yanisker GY; Lavrovskaya VM; Blant ME; Negina YP
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):167-71. PubMed ID: 4216250
    [No Abstract]   [Full Text] [Related]  

  • 38. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
    Yu X; Ma Q
    Chin J Biotechnol; 1994; 10(4):225-32. PubMed ID: 7780018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vaccination against abdominal typhus: subcutaneously or orally?].
    Huisman J
    Ned Tijdschr Geneeskd; 1984 Jul; 128(30):1425-7. PubMed ID: 6472508
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
    Hatunceva NV; Mironova MV; Ryapolova RG
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.